Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
|Podcasts|August 23, 2018
The Political Patient
Author(s)Brielle Benyon
In this week's episode, state senator Eli D. Bebout discusses his two bouts with cancer, and how his health struggles influenced his politics.
Advertisement
In this week’s episode of CURE Talks Cancer, Eli D. Bebout, a former republican state senator in Wyoming, discussed the two coincidences that ultimately led him to discover his cancer diagnoses: a Wyoming gubernatorial-election loss and an eventual swallowed fish bone that led him back into the doctor’s office.
He also discussed how he stayed motivated during his bouts with the disease and how his personal health issues influenced his politics.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
4
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
5